Yekaterina Chudnovsky
Director/Board Member presso ELICIO THERAPEUTICS, INC.
Patrimonio netto: 10 M $ in data 31/03/2024
Profilo
Yekaterina Chudnovsky is currently the Chairman at Gi Research Foundation, Director at Elicio Therapeutics, Inc. (United States), Director at xCures, Inc., Independent Director at Immix Biopharma, Inc., Independent Director at Elicio Therapeutics, Inc., and Director at Gkcc LLC.
She has an undergraduate degree from Northwestern University and a graduate degree from DePaul University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMIX BIOPHARMA, INC.
12.69% | 22/08/2023 | 3 241 076 ( 12.69% ) | 10 M $ | 31/03/2024 |
ELICIO THERAPEUTICS, INC
-.--% | 19/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Yekaterina Chudnovsky
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Board Member | 01/10/2022 |
| IMMIX BIOPHARMA, INC. | Director/Board Member | 22/08/2023 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Director/Board Member | - |
| Gkcc LLC | Director/Board Member | - |
Formazione di Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMMIX BIOPHARMA, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |
- Borsa valori
- Insiders
- Yekaterina Chudnovsky
